Arcadia Biosciences's market cap is currently ―. The company's EPS TTM is $-19.031; its P/E ratio is -0.12; Arcadia Biosciences is scheduled to report earnings on May 9, 2024, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	$ 1.60M	$ 1.38M	$ 1.51M	$ 1.00M	$ 1.88M
Gross Profit	$ 495.00K	$ 408.00K	$ 684.00K	$ -553.00K	$ 534.00K
EBIT	$ -2.62M	$ -3.80M	$ -9.38M	$ -4.48M	$ -4.56M
EBITDA	-	$ -3.56M	$ -9.13M	$ -4.20M	$ -4.47M
Net Income Common Stockholders	$ -3.17M	$ 823.00K	$ -9.38M	$ -4.24M	$ -2.87M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 15.70M	$ 18.51M	$ 23.00M	$ 20.60M	$ 22.72M
Total Assets	$ 23.47M	$ 26.80M	$ 30.41M	$ 28.92M	$ 34.47M
Total Debt	$ 1.27M	$ 1.52M	$ 1.77M	$ 2.02M	$ 2.25M
Net Debt	$ -14.43M	$ -16.98M	$ -21.23M	$ -18.58M	$ -20.46M
Total Liabilities	$ 8.07M	$ 9.07M	$ 13.72M	$ 8.02M	$ 9.46M
Stockholders Equity	$ 15.54M	$ 17.87M	$ 16.82M	$ 21.03M	$ 25.07M
Cash Flow	-
Free Cash Flow	-	$ -4.80M	$ -3.44M	$ -2.36M	$ -3.37M
Operating Cash Flow	$ -2.88M	$ -4.80M	$ -3.47M	$ -2.36M	$ -3.37M
Investing Cash Flow	$ 5.00K	$ -4.72M	$ 315.00K	$ 281.00K	$ 341.00K
Financing Cash Flow	$ 5.51M	-	$ 5.50M	-	$ 4.51M

Currency in USD

Arcadia Biosciences Earnings and Revenue History

Income Statement >

Arcadia Biosciences Debt to Assets

Balance Sheet >

Arcadia Biosciences Cash Flow

Cash Flow >

Arcadia Biosciences Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing